Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

IBUPROFEN CAPLETS - Health Canada Drug Approval Details

Approvals/Health Canada/IBUPROFEN CAPLETS

Authorized

STANDARD

IBUPROFEN CAPLETS

vita health products inc🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: d8eddca6b152abfe
Company: vita health products inc
Type: Standard

Approval Details

Approval Id: d8eddca6b152abfe
Drug Approval Canada Name: IBUPROFEN CAPLETS
Product Name: IBUPROFEN CAPLETS
Status: Marketed
Status Date: 2017-01-26
Original Market Date: 2017-01-26
Din: 02368080
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: OTC
Ahfs: 28:08.04.92
Atc Original: M01AE01 IBUPROFEN
Atc Name: m 01 ae 01
Aig Number: 0108883004
Company Name: vita health products inc
Company Address: 150 Beghin Avenue, Winnipeg, Manitoba, Canada, R2J 3W2

Active Ingredients

IBUPROFEN

200 MG

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

d8eddca6b152abfe

Type

Standard

Back to Health Canada Approvals